Ebpay生命医药出版社

Ebpay生命

102445

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

中国阻塞性睡眠呼吸暂停患病率的时空趋势:一项结合地理和人口分层的多水平荟萃分析(2000 - 2024 年)

 

Authors Niu Y, Sun S , Wang Y, Chen L, Shao Y, Zhang X

Received 3 March 2025

Accepted for publication 15 April 2025

Published 9 May 2025 Volume 2025:17 Pages 879—903

DOI http://doi.org/10.2147/NSS.S525547

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Ahmed BaHammam

Yuqi Niu, Shanwen Sun, Yali Wang, Linlin Chen, Yefan Shao, Xiaochun Zhang

Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China

Correspondence: Xiaochun Zhang, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Heping District, Shenyang, Liaoning, People’s Republic of China, Tel +86 13898824248, Email xczhang73@cmu.edu.cn

Purpose: China bears the highest global burden of obstructive sleep apnea (OSA), yet its spatiotemporal and occupational patterns remain unclear. We quantified OSA prevalence across Chinese subpopulations, focusing on geographic disparities, temporal trends, and occupational risks.
Methods: Following PRISMA guidelines, we systematically searched six databases (2000– 2024) for population-based OSA studies using polysomnography or validated portable monitoring. Two researchers independently screened studies with third-party adjudication of discrepancies. Risk of bias was assessed using Joanna Briggs Institute criteria. Random-effects models pooled prevalence estimates; meta-regression identified heterogeneity contributors. OSA diagnosis followed 2012 AASM criteria (AHI ≥ 5; pediatric studies: OAHI ≥ 1.5).
Results: From 62 studies (N=178,049), pooled OSA prevalence was 11.8% (95% CI:10.1– 13.4%), rising from 8.1% (2000– 2005) to 26.9% (2021– 2024). Prevalence was higher in males vs females (11.1% vs 6.0%, P< 0.001), with marked geographic disparities: Northwest China had the highest prevalence (17.8%, 16.3– 19.3%) versus Southwest (6.9%, 3.7– 10.9%). Drivers exhibited the highest occupational risk (15.3%). Low-quality studies overestimated prevalence (15.0% vs 7.6– 10.2% in higher-quality studies), and two-step sampling yielded higher estimates than single-risk-group designs (13.6% vs 7.4%, P< 0.001). Meta-regression identified survey period (β=0.036, P=0.025), male sex (β=− 0.062, P=0.047), geographic area (β=0.268, P=0.035), occupation (β=0.254, P=0.047), and sampling strategy (β=− 0.029, P=0.012) as key predictors of heterogeneity.
Conclusion: OSA prevalence in China has accelerated significantly. Standardized screening is urgently needed for aging populations, high-risk occupations (particularly drivers), and underserved regions. Policy priorities should address rural diagnostic inequities and integrate OSA surveillance into public health programs. Methodological harmonization is critical for tracking OSA’s evolving burden.

Keywords: obstructive sleep apnoea, OSA, prevalence, China, subgroup analysis, meta-analysis

Download Article[PDF]